Adding pirfenidone to mycophenolate mofetil shows no significant improvement in lung function compared with mycophenolate ...

Allied Market Research published a report, titled, "Dyspnea treatment Market - Global Opportunity Analysis and Industry ...

MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCM ...

Once largely a diagnosis of exclusion, new tools and treatments are unraveling some of the mysteries surrounding heart failure with preserved ejection fraction.

Among adults with evidence of systemic mast cell activation, bone marrow samples allowed for detection of 13 additional patients with the KIT D816V mutation that were not detected in peripheral blood, ...

Men and women with emphysema benefit from endoscopic lung volume reduction (ELVR), but women may have better symptom response and QoL.

Recovering from respiratory syncytial virus often doesn't end when it's time to leave the hospital, even for younger adults.

Delhi is once again facing a severe air pollution emergency, with a thick layer of smog making it almost impossible to be ...

Adult patients with CAP in a low-resource setting who were treated with adjunctive low-dose glucocorticoids had a lower risk of death.

An AHA scientific statement provides a framework for coronary revascularization in older adults, focusing on individualized care and patient preferences.

New research reveals RSV hospitalization causes lasting effects in adults of all ages—including breathlessness and reduced daily functioning months later.

The Food and Drug Administration (FDA) has granted traditional approval to Imdelltra ® (tarlatamab-dlle) for the treatment of adults with extensive stage small cell lung cancer (ES-SCLC) with disease ...